Home
October 2009 November 2009 December 2009
Su Mo Tu We Th Fr Sa
Week 45 1 2 3 4 5 6 7
Week 46 8 9 10 11 12 13 14
Week 47 15 16 17 18 19 20 21
Week 48 22 23 24 25 26 27 28
Week 49 29 30

Treatment Show Comments PDF Print E-mail
  
  • Treatment should be initiated as soon as possible after diagnosis
  • Single-dose regimens have the advantage of improved compliance and of DOT
  • To improve compliance, the medication should be provided in the clinic or health-care provider's office.

Recommended Regimens

Azithromycin 1 g orally in a single dose,
OR
Doxycycline 100 mg orally twice a day for 7 days.

Alternative Regimens

Erythromycin base 500 mg orally four times a day for 7 days,
OR
Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days,
OR
Ofloxacin 300 mg twice a day for 7 days,
OR
Levofloxacin 500 mg once daily for 7 days.

Follow-Up for Patients Who Have Urethritis

  • Patients should be instructed to return for evaluation if symptoms persist or recur after completion of therapy
  • Symptoms alone, without documentation of signs or laboratory evidence of urethral inflammation, are not a sufficient basis for re-treatment
  • Patients should be instructed to abstain from sexual intercourse until 7 days after therapy is initiated

Recurrent and Persistent Urethritis

  • Objective signs of urethritis should be present before initiation of antimicrobial therapy
  • Effective regimens have not been identified for treating patients who do not have objective signs of urethritis but who have persistent symptoms after treatment
  • Patients who have persistent or recurrent urethritis should be re-treated with the initial regimen if they did not comply with the treatment regimen or if they were reexposed to an untreated sex partner. Otherwise, a culture of an intra-urethral swab specimen and a first-void urine specimen for T. vaginalis should be performed
  • Some cases of recurrent urethritis following doxycycline treatment may be caused by tetracycline-resistant U. urealyticum
  • Urologic examinations usually do not reveal a specific etiology. If the patient was compliant with the initial regimen and re-exposure can be excluded, the following regimen is recommended.

Recommended Regimens
Metronidazole 2 g orally in a single dose
PLUS
Erythromycin base 500 mg orally four times a day for 7 days
OR
Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days.

References

Sexually Transmitted Diseases
Treatment Guidelines 2002
MMWR
Morbidity and Mortality Weekly Report
Recommendation and Reports
May 10, 2002/Vol. 51/No.RR-6

Reader Comments
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2008-08-08 18:31:58
I appreciate any and all information related to this topic. I impatiently await the day something is discovered that will help me deal with my persistant pain.
Consultant Urologist
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2007-10-21 01:50:40
Very good & informative.
MS. C.
Written by This email address is being protected from spam bots, you need Javascript enabled to view it on 2007-02-03 23:05:05
WHEN I WAS DIAGNOSED WITH I.C. 10 YEARS AGO I WAS GIVEN TEN AND A HALF MONTHS OF WEEKLY DMSO (RIMSO) INSTILLATIONS. I NOTICED MY EYESIGHT WAS BEING ADVERSLY AFFECTED DURING THIS TIME. AFTER MUCH RESEARCH THRU THE VETERINARY DEPT. AT UGA I WAS INFORMED THAT DMSO IS A SOLVENT THAT MAY ATTACK SOFT TISSUE AND THIS IN MY CASE IT WAS MY EYESIGHT. MY VISION WENT FROM 20/20 TO 20/95. I REALIZED AFTER MY RESEARCH THAT THESE TREATMENTS SHOULD HAVE BEEN DONE FOR NO MORE THAN 6 WEEKS BUT I WOULD LIKE TO ADVISE OTHER I.C. PATIENTS TO TAKE CAUTION AND DISCUSS THE POSSIBLE SIDE EFFECTS WITH THEIR UROLOGIST BEFORE PROCEEDING.

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 0
PoorBest


 

Bookmark and Share

Member's Section

Login

Sign Up

Quick Search

Featured Conference

Working with Industry

Case Studies
Sponsorship Opportunities